Log in
Enquire now

List of MiNA Therapeutics patents

List of MiNA Therapeutics patents
List of RheoSense patents
List of Artificial Cell Technologies patents
List of Quantum Machines patents
List of companies in ABRT Venture Fund's investment portfolio
List of companies in F2 Capital's investment portfolio
Patents where
Current Assignee
Name
is
MiNA TherapeuticsMiNA Therapeutics
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 9944930 Albumin production and cell proliferation

Patent 9944930 was granted and assigned to MiNA Therapeutics on April, 2018 by the United States Patent and Trademark Office.

MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9944930
April 17, 2018
‌
US Patent 9745579 Albumin production and cell proliferation

Patent 9745579 was granted and assigned to MiNA Therapeutics on August, 2017 by the United States Patent and Trademark Office.

MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9745579
August 29, 2017
‌
US Patent 11365414 Methods of inducing insulin production

Patent 11365414 was granted and assigned to MiNA Therapeutics on June, 2022 by the United States Patent and Trademark Office.

MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11365414
June 21, 2022
‌
US Patent 11566246 SIRT1-saRNA compositions and methods of use

Patent 11566246 was granted and assigned to MiNA Therapeutics on January, 2023 by the United States Patent and Trademark Office.

MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11566246
January 31, 2023
‌
US Patent 11447773 Stabilized HNF4A saRNA compositions and methods of use

MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11447773
September 20, 2022
‌
US Patent 9885046 Methods of inducing insulin production

Patent 9885046 was granted and assigned to MiNA Therapeutics on February, 2018 by the United States Patent and Trademark Office.

MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9885046
February 6, 2018
‌
US Patent 10633659 C/EBPα short activating RNA compositions and methods of use

MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10633659
April 28, 2020
‌
US Patent 10912790 C/EBP alpha saRNA compositions and methods of use

Patent 10912790 was granted and assigned to MiNA Therapeutics on February, 2021 by the United States Patent and Trademark Office.

MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10912790
February 9, 2021
‌
US Patent 9284553 Albumin production and cell proliferation

Patent 9284553 was granted and assigned to MiNA Therapeutics on March, 2016 by the United States Patent and Trademark Office.

MiNA Therapeutics
MiNA Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9284553
March 15, 2016
‌
US Patent 8916534 Methods of inducing insulin production

Patent 8916534 was granted and assigned to MiNA Therapeutics on December, 2014 by the United States Patent and Trademark Office.

MiNA Therapeutics
MiNA Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8916534
December 23, 2014
‌
US Patent 10704044 Albumin production and cell proliferation

MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10704044
July 7, 2020
‌
US Patent 10202601 C/EBPα short activating RNA compositions and methods of use

Patent 10202601 was granted and assigned to MiNA Therapeutics on February, 2019 by the United States Patent and Trademark Office.

MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10202601
February 12, 2019
‌
US Patent 10774331 Methods of inducing insulin production

MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10774331
September 15, 2020
‌
US Patent 8835400 RNA molecules that upregulate insulin production

Patent 8835400 was granted and assigned to MiNA Therapeutics on September, 2014 by the United States Patent and Trademark Office.

MiNA Therapeutics
MiNA Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8835400
September 16, 2014
‌
US Patent 11162099 HNF4A saRNA compositions and methods of use

Patent 11162099 was granted and assigned to MiNA Therapeutics on November, 2021 by the United States Patent and Trademark Office.

MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11162099
November 2, 2021
‌
US Patent 11965163 HNF4a saRNA compositions and methods of use

Patent 11965163 was granted and assigned to MiNA Therapeutics on April, 2024 by the United States Patent and Trademark Office.

MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
MiNA Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11965163
April 23, 2024
16 results
0 selected
16 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us